Moberg Pharma AB (MBGPF)
1.10
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Moberg Pharma Debt to Equity Ratio : 0.0032 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0032 |
| December 31, 2025 | 0.0038 |
| September 30, 2025 | 0.0044 |
| June 30, 2025 | 0.0049 |
| March 31, 2025 | 0.0055 |
| December 31, 2024 | 0.006 |
| September 30, 2024 | 0.0039 |
| June 30, 2024 | 0.0043 |
| March 31, 2024 | 0.0073 |
| December 31, 2023 | 0.0078 |
| September 30, 2023 | 0.0062 |
| June 30, 2023 | 0.0084 |
| March 31, 2023 | 0.0092 |
| December 31, 2022 | 0.0114 |
| September 30, 2022 | 0.0033 |
| June 30, 2022 | 0.0063 |
| March 31, 2022 | 0.0074 |
| December 31, 2021 | 0.0091 |
| September 30, 2021 | 0.0121 |
| June 30, 2021 | 0.0138 |
| March 31, 2021 | 0.0151 |
| December 31, 2020 | 0.0191 |
| September 30, 2020 | 0.0407 |
| June 30, 2020 | 0.041 |
| March 31, 2020 | 0.0269 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.0306 |
| March 31, 2019 | 0.5984 |
| December 31, 2018 | 1.001 |
| September 30, 2018 | |
| June 30, 2018 | 1.022 |
| March 31, 2018 | 1.060 |
| December 31, 2017 | 1.071 |
| September 30, 2017 | 1.096 |
| June 30, 2017 | 1.102 |
| March 31, 2017 | 1.063 |
| December 31, 2016 | 1.049 |
| September 30, 2016 | 0.9511 |
| June 30, 2016 | 0.7724 |
| March 31, 2016 | 0.8571 |
| December 31, 2015 | 0.0094 |
| September 30, 2015 | 0.0193 |
| June 30, 2015 | 0.0302 |
| March 31, 2015 | 0.0398 |
| December 31, 2014 | 0.0549 |
| September 30, 2014 | 0.068 |
| June 30, 2014 | 0.0859 |
| March 31, 2014 | 0.1291 |
| December 31, 2013 | 0.1489 |
| September 30, 2013 | 0.1661 |
| June 30, 2013 | 0.2075 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Orexo AB | 0.0192 |
| Swedencare AB | 0.253 |
| Camurus AB | 0.0249 |
| Infant Bacterial Therapeutics AB | 0.00 |
| AstraZeneca PLC | 0.7166 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 71.75M |
| Total Liabilities (Quarterly) | 1.926M |
| Shareholders Equity (Quarterly) | 69.82M |
| Current Ratio | 13.12 |
| Net Debt Paydown Yield | 0.06% |